ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,862,395 | -56.4% | 1,292,353 | -21.8% | 0.00% | -57.1% |
| Q2 2023 | $15,748,668 | -10.1% | 1,652,536 | +3.7% | 0.01% | -22.2% |
| Q1 2023 | $17,527,070 | +48.5% | 1,593,370 | +99.7% | 0.01% | +50.0% |
| Q4 2022 | $11,806,493 | -22.7% | 797,736 | -0.2% | 0.01% | -25.0% |
| Q3 2022 | $15,268,000 | -9.8% | 798,996 | +0.6% | 0.01% | 0.0% |
| Q2 2022 | $16,918,000 | +33.1% | 793,896 | +20.3% | 0.01% | +60.0% |
| Q1 2022 | $12,708,000 | -0.5% | 659,836 | +7.2% | 0.01% | 0.0% |
| Q4 2021 | $12,771,000 | -7.1% | 615,745 | +7.0% | 0.01% | 0.0% |
| Q3 2021 | $13,741,000 | -12.5% | 575,208 | -0.1% | 0.01% | -16.7% |
| Q2 2021 | $15,712,000 | -16.8% | 575,728 | -11.8% | 0.01% | -25.0% |
| Q1 2021 | $18,892,000 | – | 653,008 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,434,232 | $162,443,000 | 13.84% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $76,641,000 | 7.44% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,960,000 | 5.19% |
| Logos Global Management LP | 1,500,000 | $28,890,000 | 3.75% |
| Omega Fund Management, LLC | 623,836 | $12,015,000 | 2.46% |
| Orbimed Advisors | 6,073,850 | $116,982,000 | 1.90% |
| MPM BioImpact LLC | 258,500 | $4,979,000 | 1.34% |
| 1492 Capital Management LLC | 75,192 | $1,448,000 | 0.77% |
| SECTORAL ASSET MANAGEMENT INC | 219,136 | $4,221,000 | 0.75% |
| EcoR1 Capital, LLC | 895,503 | $17,247,000 | 0.54% |